Trials / Active Not Recruiting
Active Not RecruitingNCT06665425
PK,PD and DDI of Epaminurad and C2406 in Healthy Volunteers
An Open-label, Crossover, Phase 1 Clinical Trial to Evaluate the Pharmacokinetic/Pharmacodynamic Drug-drug Interactions and Safety/Tolerability of Epaminurad and C2406 When Co-administered in Healthy Adults
- Status
- Active Not Recruiting
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 18 (estimated)
- Sponsor
- JW Pharmaceutical · Industry
- Sex
- All
- Age
- 19 Years – 50 Years
- Healthy volunteers
- Accepted
Summary
A Phase 1 Study to evaluate the safety, PK/PD, drug-drug interaction(DDI) of Epaminurad and C2406 in Healthy Volunteers
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Epaminurad 9 mg | Period 1: Epaminurad / Period 2: C2406 -\> Epaminurad + C2406 |
| DRUG | C2406 | Period 1: Epaminurad / Period 2: C2406 -\> Epaminurad + C2406 |
Timeline
- Start date
- 2025-03-24
- Primary completion
- 2025-05-02
- Completion
- 2025-09-07
- First posted
- 2024-10-30
- Last updated
- 2025-09-09
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT06665425. Inclusion in this directory is not an endorsement.